middle.news
Health Canada Approves SCENESSE® for EPP Treatment in Adults
8:34am on Monday 13th of July, 2026 AEST
•
Pharmaceuticals
Read Story
Health Canada Approves SCENESSE® for EPP Treatment in Adults
8:34am on Monday 13th of July, 2026 AEST
Key Points
Health Canada issues Notice of Compliance for SCENESSE® in EPP
SCENESSE® is the only globally approved systemic photoprotective drug for EPP
Canadian Specialty Centers established for patient treatment
Over 21,000 SCENESSE® doses administered worldwide with long-term safety
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clinuvel Pharmaceuticals (ASX:CUV)
OPEN ARTICLE